Rakovina Therapeutics Inc (RKV) — Net Asset Quality Index
Rakovina Therapeutics Inc (RKV) has a Net Asset Quality Index of 35.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$5.27 Million minus total liabilities of CA$3.38 Million yields net assets of CA$1.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Rakovina Therapeutics Inc fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rakovina Therapeutics Inc Net Asset Quality Index Over Time (2021–2024)
This chart shows how Rakovina Therapeutics Inc's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 35.8%, representing net assets of CA$1.89 Million against total assets of CA$5.27 Million CAD. Explore RKV cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Rakovina Therapeutics Inc (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Rakovina Therapeutics Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Rakovina Therapeutics Inc.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.9% | CA$4.30 Million | CA$6.24 Million | CA$1.94 Million | ▼ -2.2 pp |
| 2023 | 71.1% | CA$3.66 Million | CA$5.15 Million | CA$1.49 Million | ▼ -27.2 pp |
| 2022 | 98.3% | CA$6.01 Million | CA$6.12 Million | CA$107.05K | ▼ -0.4 pp |
| 2021 | 98.7% | CA$8.54 Million | CA$8.66 Million | CA$113.98K | — |